You are here

Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Research Site
Shreveport, Louisiana, United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Complicated Urinary Tract Infection, Complicated Intra-abdominal Infection
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-90 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patient must be ≥18 and ≤90 years of age

- Female patients can participate if they are surgically sterile or completed menopause
or females capable of having children and agree not to attempt pregnancy while
receiving IV study therapy and for a period of 7 days after

- Patient has a ceftazidime-resistant Gram negative pathogen that was isolated from an
appropriate culture within 5 days prior to study entry (ie, within 5 days prior to
Screening; the study-qualifying culture), which was determined to be the causative
agent of the entry infection

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patient has an APACHE II score >30 (cIAI patients only)

- Patient has an infection due to Gram negative pathogen that is unlikely to respond to
CAZ-AVI treatment (eg, Acinetobacter spp., Stenotrophomonas spp.)

- Patient is receiving hemodialysis or peritoneal dialysis or had a renal transplant
Patient is immunocompromised

- Patient has a rapidly progressive or terminal illness with a high risk of mortality
due to any cause, including acute hepatic failure, respiratory failure or severe
septic shock such that they are unlikely to survive the 4- to 5-week study period.

NCT01644643
Pfizer
Completed
Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now